Daxor logo

DaxorNASDAQ: DXR

Profile

Sector:

Healthcare

Country:

United States

IPO:

25 July 1983

Next earnings report:

28 August 2024

Last dividends:

05 January 2018

Next dividends:

N/A
$43.30 M
-24%vs. 3y high
33%vs. sector
-vs. 3y high
-vs. sector
-62%vs. 3y high
45%vs. sector
-vs. 3y high
-vs. sector

Price

regular market | Mon, 01 Jul 2024 13:30:00 GMT
$9.01-$0.31(-3.33%)

Dividend

No data over the past 3 years
No data over the past 3 years
No data over the past 3 years
No data over the past 3 years

Analysts recommendations

Institutional Ownership

DXR Latest News

Daxor Corporation to Showcase the Benefits of BVA-100™ Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 20th Annual Meeting
globenewswire.com18 June 2024 Sentiment: -

Oak Ridge, TN, June 18, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today it will exhibit at the American Association of Heart Failure Nurses (AAHFN) 20th Annual Meeting from June 20-22nd, 2024 at the Rosen Shingle Creek Resort in Orlando, Florida. The AAHFN is a specialty organization dedicated to advancing nursing education, clinical practice, and research to improve heart failure patient outcomes.

Daxor Corporation (DXR) Q4 2023 Earnings Call Transcript
Seeking Alpha25 March 2024 Sentiment: NEUTRAL

Daxor Corporation (DXR) Q4 2023 Earnings Call Transcript

Daxor Corporation to Present at the H.C. Wainwright 25th Annual Global Investment Conference
GlobeNewsWire07 September 2023 Sentiment: POSITIVE

Oak Ridge, TN, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh will present at the H.C. Wainwright 25th Annual Global Investment Conference being held on September 11 - 13, 2023 at the Lotte New York Palace.

What type of business is Daxor?

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.

What sector is Daxor in?

Daxor is in the Healthcare sector

What industry is Daxor in?

Daxor is in the Medical Instruments & Supplies industry

What country is Daxor from?

Daxor is headquartered in United States

When did Daxor go public?

Daxor initial public offering (IPO) was on 25 July 1983

What is Daxor website?

https://www.daxor.com

Is Daxor in the S&P 500?

No, Daxor is not included in the S&P 500 index

Is Daxor in the NASDAQ 100?

No, Daxor is not included in the NASDAQ 100 index

Is Daxor in the Dow Jones?

No, Daxor is not included in the Dow Jones index

When does Daxor report earnings?

The next expected earnings date for Daxor is 28 August 2024